Synthesis and study of the trypanocidal activity of catechol-containing 3-arylcoumarins, inclusion in β-cyclodextrin complexes and combination with benznidazole

dc.contributor.authorPozo-Martínez, J.
dc.contributor.authorSalgado, F.
dc.contributor.authorLiempi, A.
dc.contributor.authorKemmerling, U.
dc.contributor.authorMera-Adasme, R.
dc.contributor.authorOlea-Azar, C.
dc.contributor.authorMoncada-Basualto, M.
dc.contributor.authorBorges, F.
dc.contributor.authorUriarte, E.
dc.contributor.authorMatos, M.
dc.date.accessioned2022-06-28T20:12:22Z
dc.date.available2022-06-28T20:12:22Z
dc.date.issued2022-03
dc.descriptionIndexación: Scopus.es
dc.description.abstractAmerican trypanosomiasis or Chagas disease is caused by the protozoan parasite Trypanosoma cruzi, and is considered a neglected disease, being an important problem for public health. Benznidazole (BZN) is the drug used to treat the disease. However, it has limited efficacy and adverse side effects. Therefore, the development of new therapeutic alternatives is necessary. In this work, the trypanocidal activity and cytotoxicity of a series of catechol-containing 3-arylcoumarins, their combination with BZN, and the inclusion in β-cyclodextrins (β-CDs), were evaluated. The results obtained showed that the entire series has moderate trypanocidal activity on the trypomastigote form of the parasite, being the 3-(4′-bromophenyl)-6,7-dihydroxycoumarin (8) the most active compound (IC50 = 34 μM) and the most cytotoxic in Vero cells (IC50 = 162 μM) as well. By forming the inclusion complex 8-β-CDs, the trypanocidal activity and cytotoxicity decreased. In addition, the formation of inclusion complexes increased the solubility. The possible mechanism of action of 8 was evaluated and proved to be through the generation of oxidative stress. The combination with BZN presented a synergistic effect on the trypanocidal activity, reducing the necessary dose of BZN. The presence of a catechol in the studied scaffold seems to modulate the trypanocidal activity, and the combination of drugs proved to be a promising alternative strategy for treating the disease.es
dc.description.urihttps://www-sciencedirect-com.recursosbiblioteca.unab.cl/science/article/pii/S1878535221006560?via%3Dihub
dc.identifier.citationArabian Journal of Chemistry, Volume 15, Issue 3, March 2022, Article number 103641es
dc.identifier.doi10.1016/j.arabjc.2021.103641
dc.identifier.issn1878-5352
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/23033
dc.language.isoenes
dc.publisherElsevier B.V.es
dc.rights.licenseAttribution 4.0 International (CC BY 4.0)
dc.rights.urihttps://s100.copyright.com/AppDispatchServlet?publisherName=ELS&contentID=S1878535221006560&orderBeanReset=true
dc.subject3-Arylcoumarinses
dc.subjectBenznidazole synergyes
dc.subjectChagas diseasees
dc.subjectInclusion complexes
dc.subjectTrypanosoma cruzies
dc.subject2 Hydroxypropyl Beta Cyclodextrines
dc.subjectCyclodextrinses
dc.subjectComplexationes
dc.titleSynthesis and study of the trypanocidal activity of catechol-containing 3-arylcoumarins, inclusion in β-cyclodextrin complexes and combination with benznidazolees
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Pozo-Martinez_Synthesis and study of the trypanocidal activity of catechol-containing 3-arylcoumarins, inclusion in β-cyclodextrin complexes and combination with benznidazole.pdf
Tamaño:
2.38 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLES
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción: